Key risks
- PE of 28.37 is elevated — verify if growth assumptions in recent filings justify the multiple, or if earnings miss risks significant correction
- ROE, OPM, D/E all n/a — researcher must verify actual profit margins, return on equity, and debt levels from latest financial statements
- Market cap ₹355.23 Cr — typical small-cap risks: higher volatility, lower liquidity, limited analyst coverage
- Specialty chemicals subject to customer concentration and commodity pricing — verify client base diversification and pricing strategy
Generated analysis · source review pending